assertion (references)

Nanopublication	Part	Subject	Predicate	Object	Published By	Published On
http://purl.org/np/RAjbC2DOpW... RAjbC2DOpW	links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance	assertion	http://www.w3.org/ns/prov#wasAttributedTo wasAttributedTo	https://orcid.org/0000-0002-3668-2627 Elif Ozkan	Elif Ozkan	2022-10-13T12:47:09.419Z
http://purl.org/np/RAjbC2DOpW... RAjbC2DOpW	links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance	assertion	http://www.w3.org/ns/prov#generatedAtTime generatedAtTime	2022-10-13T12:47:09.419174	Elif Ozkan	2022-10-13T12:47:09.419Z
http://purl.org/np/RAjbC2DOpW... RAjbC2DOpW	links a nanopublication to its provenance http://www.nanopub.org/nschema#hasProvenance provenance	assertion	http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom	Sacubitril is used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) It is usually administered in conjunction with other heart failure therapies, in place of an ACE inhibitor or other ARB. It is also used in. combination with. an ACE. inhibitor or an ARB, it is usually used in conjunction.	Elif Ozkan	2022-10-13T12:47:09.419Z